Lennox GK - Search Results

1

Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?

Lennox GK, Eiriksson LR, Reade CJ, Leung F, Mojtahedi G, Atenafu EG, Ferguson SE, Murphy J, Diamandis EP, Kulasingam V, Bernardini MQ. Lennox GK, et al. Int J Gynecol Cancer. 2015 Jun;25(5):809-14. doi: 10.1097/IGC.0000000000000442. Int J Gynecol Cancer. 2015. PMID: 25855958

2

Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma.

Hogen L, Vicus D, Ferguson SE, Gien LT, Nofech-Mozes S, Lennox GK, Bernardini MQ. Hogen L, et al. Among authors: lennox gk. Int J Gynecol Cancer. 2019 Sep;29(7):1164-1169. doi: 10.1136/ijgc-2019-000287. Epub 2019 Jul 3. Int J Gynecol Cancer. 2019. PMID: 31273067

3

Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?

Lennox GK, Clark M, Zigras T, Rouzbahman M, Han G, Bernardini MQ, Gien LT. Lennox GK, et al. J Obstet Gynaecol Can. 2021 May;43(5):564-570. doi: 10.1016/j.jogc.2020.12.017. Epub 2021 Jan 4. J Obstet Gynaecol Can. 2021. PMID: 33412305

4

Identifying Borderline Ovarian Tumor Recurrence Using Routine Ultrasound Follow-Up.

Lazurko C, Feigenberg T, Murphy J, Pulman K, Lennox G, Dube V, Zigras T. Lazurko C, et al. Cancers (Basel). 2022 Dec 22;15(1):73. doi: 10.3390/cancers15010073. Cancers (Basel). 2022. PMID: 36612070 Free PMC article.

5

Hormone maintenance therapy for women with low-grade serous ovarian cancer in the front-line setting: A systematic review.

Lazurko C, Clark M, Pulman K, Lennox G, May T, Fazelzad R, Gien LT, Zigras T. Lazurko C, et al. Gynecol Oncol. 2021 Oct;163(1):209-214. doi: 10.1016/j.ygyno.2021.07.027. Epub 2021 Jul 27. Gynecol Oncol. 2021. PMID: 34325937

6

Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review.

Lazurko C, Linder R, Pulman K, Lennox G, Feigenberg T, Fazelzad R, May T, Zigras T. Lazurko C, et al. Curr Oncol. 2023 Sep 3;30(9):8159-8171. doi: 10.3390/curroncol30090592. Curr Oncol. 2023. PMID: 37754507 Free PMC article. Review.

7

Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?

Lennox GK, Covens A. Lennox GK, et al. Gynecol Oncol. 2017 Jul;146(1):1-2. doi: 10.1016/j.ygyno.2017.06.006. Gynecol Oncol. 2017. PMID: 28625331 No abstract available.

8

Early Cervical Cancer: Current Dilemmas of Staging and Surgery.

Zigras T, Lennox G, Willows K, Covens A. Zigras T, et al. Curr Oncol Rep. 2017 Aug;19(8):51. doi: 10.1007/s11912-017-0614-5. Curr Oncol Rep. 2017. PMID: 28664470 Review.

9

Highlighting obesity as a risk factor for endometrial cancer.

Simpson AN, Lennox G. Simpson AN, et al. CMAJ. 2021 Jan 11;193(2):E58. doi: 10.1503/cmaj.77367. CMAJ. 2021. PMID: 33431549 Free PMC article. No abstract available.

10

Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?

Lennox GK, Covens A. Lennox GK, et al. Gynecol Oncol. 2017 Jan;144(1):16-20. doi: 10.1016/j.ygyno.2016.08.337. Epub 2016 Oct 11. Gynecol Oncol. 2017. PMID: 27742472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters